Cargando…

Genomic signatures characterize leukocyte infiltration in myositis muscles

BACKGROUND: Leukocyte infiltration plays an important role in the pathogenesis and progression of myositis, and is highly associated with disease severity. Currently, there is a lack of: efficacious therapies for myositis; understanding of the molecular features important for disease pathogenesis; a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wei, Streicher, Katie, Shen, Nan, Higgs, Brandon W, Morehouse, Chris, Greenlees, Lydia, Amato, Anthony A, Ranade, Koustubh, Richman, Laura, Fiorentino, David, Jallal, Bahija, Greenberg, Steven A, Yao, Yihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541209/ https://www.ncbi.nlm.nih.gov/pubmed/23171592 http://dx.doi.org/10.1186/1755-8794-5-53

Ejemplares similares

microRNA-mediated regulation of innate immune response in rheumatic diseases
por: Luo, Xiaobing, et al.
Publicado: (2013)

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
por: Higgs, Brandon W, et al.
Publicado: (2014)

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
por: Yao, Yihong, et al.
Publicado: (2010)

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
por: Jiang, Liyan, et al.
Publicado: (2014)

Altered Expression of Insulin Receptor Isoforms in Breast Cancer
por: Huang, Jiaqi, et al.
Publicado: (2011)

Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2008)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
por: Yao, Yihong, et al.
Publicado: (2009)

Developing innovative targeted therapies for China
por: Jallal, Bahija
Publicado: (2012)

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
por: Wong, David, et al.
Publicado: (2012)

Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay
por: Hemken, Philip M., et al.
Publicado: (2017)

Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma
por: Cheng, Li, et al.
Publicado: (2021)

Type 1 interferons and myositis
por: Greenberg, Steven A
Publicado: (2010)

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
por: Jiang, Liyan, et al.
Publicado: (2016)

Leukocyte infiltration in experimental stroke
por: Grønberg, Nina Vindegaard, et al.
Publicado: (2013)

High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease
por: Higgs, Brandon W., et al.
Publicado: (2017)

Compartment Syndrome of All Extremities in the Setting of COVID-19-Induced Systemic Capillary Leak Syndrome With Superimposed Myositis
por: Zeller, Robert B, et al.
Publicado: (2023)

Myositis
Publicado: (2009)

Myositis
por: Korsten, Peter, et al.
Publicado: (2022)

The meningeal and choroidal infiltration routes for leukocytes in stroke
por: Benakis, Corinne, et al.
Publicado: (2018)

NGAL promotes recruitment of tumor infiltrating leukocytes
por: Pacifico, Francesco, et al.
Publicado: (2018)

Gene expression markers of Tumor Infiltrating Leukocytes
por: Danaher, Patrick, et al.
Publicado: (2017)

12. When is inflammatory myositis not inflammatory myositis?
por: McShane, Annmarie, et al.
Publicado: (2019)

Endothelial cell regulation of leukocyte infiltration in inflammatory tissues
por: Duperray, A., et al.
Publicado: (1995)

Leukocyte infiltration as a surrogate marker for diagnosis of invasion
por: Liu, Aijun, et al.
Publicado: (2010)

Purinergic Signaling on Leukocytes Infiltrating the LPS-Injured Lung
por: Friebe, Daniela, et al.
Publicado: (2014)

Somatic mutations in leukocytes infiltrating primary breast cancers
por: Kleppe, Maria, et al.
Publicado: (2015)

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study
por: Diop, Mame-Kany, et al.
Publicado: (2023)

Myositis Ossificans
por: Yu Chuah, Tyng, et al.
Publicado: (2011)

Nonbacterial Myositis
por: Crum-Cianflone, Nancy F.
Publicado: (2010)

T cells in myositis
por: Malmström, Vivianne, et al.
Publicado: (2012)

Acute Myositis
por: Viswanathan, R.
Publicado: (1949)

Exercise in Myositis
por: Alexanderson, Helene
Publicado: (2018)

Myositis and Myonecrosis
por: Pasternack, Mark S., et al.
Publicado: (2015)

Infective myositis
por: Narayanappa, Gayathri, et al.
Publicado: (2021)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis
por: Salajegheh, Mohammad, et al.
Publicado: (2011)

The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human
por: Korpos, Éva, et al.
Publicado: (2013)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

The EuroMyositis registry: an international collaborative tool to facilitate myositis research
por: Lilleker, James B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v1ofa5ffcqkdk5fub0s1efr1a3